Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Marinos Dalakas MD, FAAN
Marinos C. Dalakas MD, FAAN Advisory Board
Argye Hillis MD, MA
Argye Elizabeth Hillis MD, MA Associate Editor
Mark Hallett MD
Mark Hallett MD Editor-in-Chief
See All Experts
Published in Neurology

Journal Scan / Research · March 27, 2023

Prediction of Longitudinal Cognitive Decline in Patients With Preclinical Alzheimer's Disease Using Plasma Biomarkers

JAMA Neurology

 

 Save  Recommend
 Share

Additional Info

JAMA Neurology
Prediction of Longitudinal Cognitive Decline in Preclinical Alzheimer Disease Using Plasma Biomarkers
JAMA Neurol 2023 Feb 06;[EPub Ahead of Print], N Mattsson-Carlgren, G Salvadó, NJ Ashton, P Tideman, E Stomrud, H Zetterberg, R Ossenkoppele, TJ Betthauser, KA Cody, EM Jonaitis, R Langhough, S Palmqvist, K Blennow, S Janelidze, SC Johnson, O Hansson

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading

Most Read This Week

Recently Updated